查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
手術後疼痛治療藥的全球市場:各藥物類別 - 產業分析，規模，佔有率，成長，趨勢，預測(2022年～2031年)
市場調查報告書
商品編碼
1140653

手術後疼痛治療藥的全球市場:各藥物類別 - 產業分析，規模，佔有率，成長，趨勢，預測(2022年～2031年)

Post-operative Pain Therapeutics Market (Drug Class: NSAIDs, Opioids, Local Anesthetics, Antiepileptic Drugs, Tricyclic Antidepressants, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
出版日期: | 出版商: Transparency Market Research | 英文 190 Pages | 商品交期: 2-10個工作天內

價格

本報告提供全球手術後疼痛治療藥市場相關調查分析，提供市場趨勢，市場區隔分析，地區分析，企業簡介等資訊。

目錄

第1章 序文

第2章 前提與調查手法

第3章 摘要整理:全球手術後疼痛治療藥市場

第4章 市場概要

  • 簡介
    • 市場區隔定義
  • 概要
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會

第5章 主要考察

  • 手術數量(整形外科，一般手術，整形外科，婦產科，眼科等)(2020年～2021年)
    • 北美(美國·加拿大)
    • 歐洲聯盟(德國·英國·法國·義大利·西班牙)
    • 亞太地區(日本·中國·印度·新加坡·韓國)
    • 南美(巴西·墨西哥·阿根廷)
  • 產品分析 - 包裝，尺寸，價格
  • 主要的產業的發展
  • 開發平台分析
  • 法規情景的評估
  • 術後管理必要的所有手術概要
    • 手術後疼痛管理必要的美國的手術
  • COVID-19影響的分析

第6章 全球手術後疼痛治療藥市場分析與預測:各藥物類別

  • 簡介和定義
  • 主要調查結果/發展
  • 市場金額的預測:各藥物類別(2017年～2031年)
    • 類鴉片物質
    • NSAID
    • 局部麻醉劑
    • 三環抗憂鬱藥物
    • 抗癲癇藥
    • 其他
  • 市場魅力分析:各藥物類別

第7章 全球手術後疼痛治療藥市場分析與預測:各給藥途徑

  • 簡介和定義
  • 主要調查結果/發展
  • 市場金額的預測:各給藥途徑(2017年～2031年)
    • 口服
    • 靜脈
    • 肌肉
    • 其他
  • 市場魅力分析:各給藥途徑

第8章 全球手術後疼痛治療藥市場分析與預測:各流通管道

  • 簡介和定義
  • 主要調查結果/發展
  • 市場金額的預測:各流通管道(2017年～2031年)
    • 醫院藥局
    • 零售藥局
    • 線上藥局
    • 其他
  • 市場魅力分析:各流通管道

第9章 全球手術後疼痛治療藥市場分析與預測:各地區

  • 主要調查結果
  • 市場金額的預測:各地區
    • 美國
    • 歐洲聯盟(EU5個國家)
    • 亞太地區
    • 南美
    • 其他地區(RoW)
  • 市場魅力分析:各地區

第10章 美國的手術後疼痛治療藥市場分析與預測

  • 簡介
    • 主要調查結果
  • 市場金額的預測:各藥物類別(2017年～2031年)
  • 市場金額的預測:各給藥途徑(2017年～2031年)
  • 市場金額的預測:各流通管道(2017年～2031年)
  • 市場金額的預測:各國(2017年～2031年)
  • 市場魅力分析
    • 各藥物類別
    • 各給藥途徑
    • 各流通管道

第11章 歐洲聯盟(EU5個國家)的手術後疼痛治療藥市場分析與預測

第12章 亞太地區的手術後疼痛治療藥市場分析與預測

第13章 南美的手術後疼痛治療藥市場分析與預測

第14章 其他地區(RoW)的手術後疼痛治療藥市場分析與預測

第15章 競爭情形

  • 競爭的事業策略
  • 企業簡介
    • Mallinckrodt Pharmaceuticals
    • Pfizer, Inc.
    • Novartis AG
    • Eli Lilly and Company
    • Teva Pharmaceutical Industries Ltd.
    • Camurus AB
    • Bayer AG
    • Pacira BioSciences, Inc.
    • Trevena, Inc.
Product Code: TMRGL67271

The report provides revenue of the global post-operative pain therapeutics market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global post-operative pain therapeutics market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the post-operative pain therapeutics market.

The report delves into the competitive landscape of the global post-operative pain therapeutics market. Key players operating in the global post-operative pain therapeutics market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global post-operative pain therapeutics market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Post-operative Pain Therapeutics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities

5. Key Insights

  • 5.1. No. of Surgical Procedure Volume, (Orthopedic Surgery, General Surgery, Plastic Surgery, Gynecological Surgery, Ophthalmic Surgery etc.), 2020-2021
    • 5.1.1. North America (U.S. and Canada)
    • 5.1.2. European Union (Germany, U.K. France, Italy and Spain)
    • 5.1.3. Asia Pacific (Japan, China, India, Singapore and Korea)
    • 5.1.4. Latin America (Brazil, Mexico and Argentina)
  • 5.2. Product Analysis- Packaging, Size, and Price
  • 5.3. Key Industry Development
  • 5.4. Pipeline Analysis
  • 5.5. Regulatory Scenario Assessment
  • 5.6. Overview of Total Surgical Procedures Requiring Postoperative Management
    • 5.6.1. U.S. Surgical Procedures Requiring Postoperative Pain Management
  • 5.7. COVID-19 Impact Analysis

6. Global Post-operative Pain Therapeutics Market Analysis and Forecast, by Drug Class

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Drug Class, 2017-2031
    • 6.3.1. Opioids
    • 6.3.2. NSAIDs
    • 6.3.3. Local Anesthetics
    • 6.3.4. Tricyclic Antidepressants
    • 6.3.5. Antiepileptic Drugs
    • 6.3.6. Others
  • 6.4. Market Attractiveness Analysis, by Drug Class

7. Global Post-operative Pain Therapeutics Market Analysis and Forecast, by Route of Administration

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Route of Administration, 2017-2031
    • 7.3.1. Oral
    • 7.3.2. Intravenous
    • 7.3.3. Intramuscular
    • 7.3.4. Others
  • 7.4. Market Attractiveness Analysis, by Route of Administration

8. Global Post-operative Pain Therapeutics Market Analysis and Forecast, by Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Online Pharmacies
    • 8.3.4. Others
  • 8.4. Market Attractiveness Analysis, by Distribution Channel

9. Global Post-operative Pain Therapeutics Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. U.S.
    • 9.2.2. European Union (EU5)
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Rest of the World (RoW)
  • 9.3. Market Attractiveness Analysis, by Region

10. U.S. Post-operative Pain Therapeutics Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Drug Class, 2017-2031
    • 10.2.1. Opioids
    • 10.2.2. NSAIDs
    • 10.2.3. Local Anesthetics
    • 10.2.4. Tricyclic Antidepressants
    • 10.2.5. Antiepileptic Drugs
    • 10.2.6. Others
  • 10.3. Market Value Forecast, by Route of Administration, 2017-2031
    • 10.3.1. Oral
    • 10.3.2. Intravenous
    • 10.3.3. Intramuscular
    • 10.3.4. Others
  • 10.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 10.4.1. Hospital Pharmacies
    • 10.4.2. Retail Pharmacies
    • 10.4.3. Online Pharmacies
    • 10.4.4. Others
  • 10.5. Market Value Forecast, by Country, 2017-2031
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Drug Class
    • 10.6.2. By Route of Administration
    • 10.6.3. By Distribution Channel

11. European Union (EU5) Post-operative Pain Therapeutics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Drug Class, 2017-2031
    • 11.2.1. Opioids
    • 11.2.2. NSAIDs
    • 11.2.3. Local Anesthetics
    • 11.2.4. Tricyclic Antidepressants
    • 11.2.5. Antiepileptic Drugs
    • 11.2.6. Others
  • 11.3. Market Value Forecast, by Route of Administration, 2017-2031
    • 11.3.1. Oral
    • 11.3.2. Intravenous
    • 11.3.3. Intramuscular
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 11.4.1. Hospital Pharmacies
    • 11.4.2. Retail Pharmacies
    • 11.4.3. Online Pharmacies
    • 11.4.4. Others
  • 11.5. Market Value Forecast, by Country, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. France
    • 11.5.3. U.K.
    • 11.5.4. Italy
    • 11.5.5. Spain
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Drug Class
    • 11.6.2. By Route of Administration
    • 11.6.3. By Distribution Channel
    • 11.6.4. By Country

12. Asia Pacific Post-operative Pain Therapeutics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Drug Class, 2017-2031
    • 12.2.1. Opioids
    • 12.2.2. NSAIDs
    • 12.2.3. Local Anesthetics
    • 12.2.4. Tricyclic Antidepressants
    • 12.2.5. Antiepileptic Drugs
    • 12.2.6. Others
  • 12.3. Market Value Forecast, by Route of Administration, 2017-2031
    • 12.3.1. Oral
    • 12.3.2. Intravenous
    • 12.3.3. Intramuscular
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 12.4.1. Hospital Pharmacies
    • 12.4.2. Retail Pharmacies
    • 12.4.3. Online Pharmacies
    • 12.4.4. Others
  • 12.5. Market Value Forecast, by Country, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. South Korea
    • 12.5.4. Singapore
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Drug Class
    • 12.6.2. By Route of Administration
    • 12.6.3. By Distribution Channel
    • 12.6.4. By Country

13. Latin America Post-operative Pain Therapeutics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Drug Class, 2017-2031
    • 13.2.1. Opioids
    • 13.2.2. NSAIDs
    • 13.2.3. Local Anesthetics
    • 13.2.4. Tricyclic Antidepressants
    • 13.2.5. Antiepileptic Drugs
    • 13.2.6. Others
  • 13.3. Market Value Forecast, by Route of Administration, 2017-2031
    • 13.3.1. Oral
    • 13.3.2. Intravenous
    • 13.3.3. Intramuscular
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 13.4.1. Hospital Pharmacies
    • 13.4.2. Retail Pharmacies
    • 13.4.3. Online Pharmacies
    • 13.4.4. Others
  • 13.5. Market Value Forecast, by Country, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Argentina
    • 13.5.3. Chile
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Drug Class
    • 13.6.2. By Route of Administration
    • 13.6.3. By Distribution Channel
    • 13.6.4. By Country

14. Rest of the World (RoW) Post-operative Pain Therapeutics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Drug Class, 2017-2031
    • 14.2.1. Opioids
    • 14.2.2. NSAIDs
    • 14.2.3. Local Anesthetics
    • 14.2.4. Tricyclic Antidepressants
    • 14.2.5. Antiepileptic Drugs
    • 14.2.6. Others
  • 14.3. Market Value Forecast, by Route of Administration, 2017-2031
    • 14.3.1. Oral
    • 14.3.2. Intravenous
    • 14.3.3. Intramuscular
    • 14.3.4. Others
  • 14.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 14.4.1. Hospital Pharmacies
    • 14.4.2. Retail Pharmacies
    • 14.4.3. Online Pharmacies
    • 14.4.4. Others
  • 14.5. Market Value Forecast, by Country, 2017-2031
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Drug Class
    • 14.6.2. By Route of Administration
    • 14.6.3. By Distribution Channel

15. Competition Landscape

  • 15.1. Competitive Business Strategies
  • 15.2. Company Profiles
    • 15.2.1. Mallinckrodt Pharmaceuticals
      • 15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.1.2. Product Portfolio
      • 15.2.1.3. SWOT Analysis
      • 15.2.1.4. Strategic Overview
    • 15.2.2. Pfizer, Inc.
      • 15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.2.2. Product Portfolio
      • 15.2.2.3. SWOT Analysis
      • 15.2.2.4. Strategic Overview
    • 15.2.3. Novartis AG
      • 15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.3.2. Product Portfolio
      • 15.2.3.3. SWOT Analysis
      • 15.2.3.4. Strategic Overview
    • 15.2.4. Eli Lilly and Company
      • 15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.4.2. Product Portfolio
      • 15.2.4.3. SWOT Analysis
      • 15.2.4.4. Strategic Overview
    • 15.2.5. Teva Pharmaceutical Industries Ltd.
      • 15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.5.2. Product Portfolio
      • 15.2.5.3. SWOT Analysis
      • 15.2.5.4. Strategic Overview
    • 15.2.6. Camurus AB
      • 15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.6.2. Product Portfolio
      • 15.2.6.3. SWOT Analysis
      • 15.2.6.4. Strategic Overview
    • 15.2.7. Bayer AG
      • 15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.7.2. Product Portfolio
      • 15.2.7.3. SWOT Analysis
      • 15.2.7.4. Strategic Overview
    • 15.2.8. Pacira BioSciences, Inc.
      • 15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.8.2. Product Portfolio
      • 15.2.8.3. SWOT Analysis
      • 15.2.8.4. Strategic Overview
    • 15.2.9. Trevena, Inc.
      • 15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.9.2. Product Portfolio
      • 15.2.9.3. SWOT Analysis
      • 15.2.9.4. Strategic Overview

List of Tables

  • Table 01: Global Post-operative Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017-2031
  • Table 02: Global Post-operative Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 03: Global Post-operative Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 04: Global Post-operative Pain Therapeutics Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: U.S. Post-operative Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017-2031
  • Table 06: U.S. Post-operative Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 07: U.S. Post-operative Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 08: European Union (EU5) Post-operative Pain Therapeutics Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 09: European Union (EU5) Post-operative Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017-2031
  • Table 10: European Union (EU5) Post-operative Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 11: European Union (EU5) Post-operative Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 12: Asia Pacific Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 13: Asia Pacific Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017-2031
  • Table 14: Asia Pacific Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 15: Asia Pacific Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 16: Latin America Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 17: Latin America Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017-2031
  • Table 18: Latin America Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 19: Latin America Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 20: Rest of the World Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2017-2031
  • Table 21: Rest of the World Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 22: Rest of the World Postoperative Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031

List of Figures

  • Figure 01: Global Post-operative Pain Therapeutics Market, by Drug Class, 2021 and 2031
  • Figure 02: Global Post-operative Pain Therapeutics Market Attractiveness Analysis, by Drug Class, 2022-2031
  • Figure 03: Global Post-operative Pain Therapeutics Market (US$ Mn), by Opioids, 2017-2031
  • Figure 04: Global Post-operative Pain Therapeutics Market (US$ Mn), by NSAIDs, 2017-2031
  • Figure 05: Global Post-operative Pain Therapeutics Market (US$ Mn), by Local Anesthetics, 2017-2031
  • Figure 06: Global Post-operative Pain Therapeutics Market (US$ Mn), by Tricyclic Antidepressants, 2017-2031
  • Figure 07: Global Post-operative Pain Therapeutics Market (US$ Mn), by Antiepileptic Drugs, 2017-2031
  • Figure 08: Global Post-operative Pain Therapeutics Market (US$ Mn), by Others, 2017-2031
  • Figure 09: Global Post-operative Pain Therapeutics Market, by Route of Administration, 2021 and 2031
  • Figure 10: Global Post-operative Pain Therapeutics Market Attractiveness Analysis, by Route of Administration, 2022-2031
  • Figure 11: Global Post-operative Pain Therapeutics Market (US$ Mn), by Oral, 2017-2031
  • Figure 12: Global Post-operative Pain Therapeutics Market (US$ Mn), by Intravenous, 2017-2031
  • Figure 13: Global Post-operative Pain Therapeutics Market (US$ Mn), by Intramuscular, 2017-2031
  • Figure 14: Global Post-operative Pain Therapeutics Market (US$ Mn), by Others, 2017-2031
  • Figure 15: Global Post-operative Pain Therapeutics Market, by Distribution Channel, 2021 and 2031
  • Figure 16: Global Post-operative Pain Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 17: Global Post-operative Pain Therapeutics Market (US$ Mn), by Hospital Pharmacies, 2017-2031
  • Figure 18: Global Post-operative Pain Therapeutics Market (US$ Mn), by Retail Pharmacies, 2017-2031
  • Figure 19: Global Post-operative Pain Therapeutics Market (US$ Mn), by Online Pharmacies, 2017-2031
  • Figure 20: Global Post-operative Pain Therapeutics Market (US$ Mn), by Others, 2017-2031
  • Figure 21: Global Post-operative Pain Therapeutics Market, by Region, 2021 and 2031
  • Figure 22: Global Post-operative Pain Therapeutics Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 23: U.S. Post-operative Pain Therapeutics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 24: U.S. Post-operative Pain Therapeutics Market, by Drug Class, 2021 and 2031
  • Figure 25: U.S. Post-operative Pain Therapeutics Market Attractiveness Analysis, by Drug Class, 2022-2031
  • Figure 26: U.S. Post-operative Pain Therapeutics Market, by Route of Administration, 2021 and 2031
  • Figure 27: U.S. Post-operative Pain Therapeutics Market Attractiveness Analysis, by Route of Administration, 2022-2031
  • Figure 28: U.S. Post-operative Pain Therapeutics Market, by Distribution Channel, 2021 and 2031
  • Figure 29: U.S. Post-operative Pain Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 30: European Union (EU5) Post-operative Pain Therapeutics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 31: European Union (EU5) Post-operative Pain Therapeutics Market, by Country/Region, 2021 and 2031
  • Figure 32: European Union (EU5) Post-operative Pain Therapeutics Market Attractiveness Analysis, by Country/Region, 2022-2031
  • Figure 33: European Union (EU5) Post-operative Pain Therapeutics Market, by Drug Class, 2021 and 2031
  • Figure 34: European Union (EU5) Post-operative Pain Therapeutics Market Attractiveness Analysis, by Drug Class, 2022-2031
  • Figure 35: European Union (EU5) Post-operative Pain Therapeutics Market, by Route of Administration, 2021 and 2031
  • Figure 36: European Union (EU5) Post-operative Pain Therapeutics Market Attractiveness Analysis, by Route of Administration, 2022-2031
  • Figure 37: European Union (EU5) Post-operative Pain Therapeutics Market, by Distribution Channel, 2021 and 2031
  • Figure 38: European Union (EU5) Post-operative Pain Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 39: Asia Pacific Post-operative Pain Therapeutics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 40: Asia Pacific Post-operative Pain Therapeutics Market, by Country, 2021 and 2031
  • Figure 41: Asia Pacific Post-operative Pain Therapeutics Market Attractiveness Analysis, by Country, 2022-2031
  • Figure 42: Asia Pacific Post-operative Pain Therapeutics Market, by Drug Class, 2021 and 2031
  • Figure 43: Asia Pacific Post-operative Pain Therapeutics Market Attractiveness Analysis, by Drug Class, 2022-2031
  • Figure 44: Asia Pacific Post-operative Pain Therapeutics Market, by Route of Administration, 2021 and 2031
  • Figure 45: Asia Pacific Post-operative Pain Therapeutics Market Attractiveness Analysis, by Route of Administration, 2022-2031
  • Figure 46: Asia Pacific Post-operative Pain Therapeutics Market, by Distribution Channel, 2021 and 2031
  • Figure 47: Asia Pacific Post-operative Pain Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 48: Latin America Post-operative Pain Therapeutics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 49: Latin America Post-operative Pain Therapeutics Market, by Country, 2021 and 2031
  • Figure 50: Latin America Post-operative Pain Therapeutics Market Attractiveness Analysis, by Country, 2022-2031
  • Figure 51: Latin America Post-operative Pain Therapeutics Market, by Drug Class, 2021 and 2031
  • Figure 52: Latin America Post-operative Pain Therapeutics Market Attractiveness Analysis, by Drug Class, 2022-2031
  • Figure 53: Latin America Post-operative Pain Therapeutics Market, by Route of Administration, 2021 and 2031
  • Figure 54: Latin America Post-operative Pain Therapeutics Market Attractiveness Analysis, by Route of Administration, 2022-2031
  • Figure 55: Latin America Post-operative Pain Therapeutics Market, by Distribution Channel, 2021 and 2031
  • Figure 56: Latin America Post-operative Pain Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 57: Rest of the World Post-operative Pain Therapeutics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 58: Rest of the World Post-operative Pain Therapeutics Market, by Drug Class, 2021 and 2031
  • Figure 59: Rest of the World Post-operative Pain Therapeutics Market Attractiveness Analysis, by Drug Class, 2022-2031
  • Figure 60: Rest of the World Post-operative Pain Therapeutics Market, by Route of Administration, 2021 and 2031
  • Figure 61: Rest of the World Post-operative Pain Therapeutics Market Attractiveness Analysis, by Route of Administration, 2022-2031
  • Figure 62: Rest of the World Post-operative Pain Therapeutics Market, by Distribution Channel, 2021 and 2031
  • Figure 63: Rest of the World Post-operative Pain Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2022-2031